Vanessa Sousa Pereira

Ms. Vanessa Sousa Pereira

Universidade Estadual de Campinas, Campinas, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MMMarcel Franco Mougenot
Marcel Franco Mougenot
VPVanessa Sousa Pereira
Vanessa Sousa Pereira
ACAna Letícia Rodrigues Costa
Ana Letícia Rodrigues Costa
Marcelo LancellottiMarcelo Lancellotti
Marcelo Lancellotti
MPMarimelia Porcionatto
Marimelia Porcionatto
Lucimara de la TorreLucimara de la Torre
Lucimara de la Torre
Despite all the progress in the field of liposomes and nanoparticles for applications as drug and gene delivery systems, the specific targeting and immune system escape capabilities of these systems are still limited. Biomimetic nanovesicles emerged as a strategy to overcome these and other limitations associated with synthetic carriers, such as short circulation time, cytotoxicity, and difficulty in crossing biological barriers, since many of the desirable abilities of drug delivery systems are innate characteristics of biological vesicles. Thus, the question arises: would biomimetic nanovesicles be responsible for addressing these advances? It is currently known that biomimetic nanovesicles (BNV) can combine the intrinsic advantages of natural materials with the well-known production methods and controllability of synthetic systems. Besides, the development of the biotechnology and nanotechnology fields has provided a better understanding of the functionalities of biological vesicles and the means for the design and production of biomimetic nanovesicles (BNV). Based on this, this work will focus on tracking the main research on biomimetic nanovesicles (BNV) applied as drug and gene delivery systems, and for vaccines applications. In addition, it will describe the different sources of natural vesicles, the technical perspectives on obtaining them, and the possibility of their hybridization with synthetic liposomes.